UG1EY028087
Cooperative Agreement
Overview
Grant Description
ADALIMIMAB VS CONVENTIONAL IMMUNOSUPPRESSION FOR UVEITIS (ADVISE) TRIAL
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Madison,
Wisconsin
53715
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/23 to 08/31/25 and the total obligations have increased 757% from $149,338 to $1,280,176.
University Of Wisconsin System was awarded
ADalimimab Vs conventional ImmunoSupprEssion for uveitis (ADVISE) Trial
Cooperative Agreement UG1EY028087
worth $1,280,176
from National Eye Institute in September 2018 with work to be completed primarily in Madison Wisconsin United States.
The grant
has a duration of 7 years and
was awarded through assistance program 93.867 Vision Research.
The Cooperative Agreement was awarded through grant opportunity NEI Clinical Vision Research: Coordinating Center Grant (UG1).
Status
(Complete)
Last Modified 8/20/24
Period of Performance
9/30/18
Start Date
8/31/25
End Date
Funding Split
$1.3M
Federal Obligation
$0.0
Non-Federal Obligation
$1.3M
Total Obligated
Activity Timeline
Transaction History
Modifications to UG1EY028087
Additional Detail
Award ID FAIN
UG1EY028087
SAI Number
UG1EY028087-3091505083
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NW00 NIH NATIONAL EYE INSTITUTE
Funding Office
75NW00 NIH NATIONAL EYE INSTITUTE
Awardee UEI
LCLSJAGTNZQ7
Awardee CAGE
09FZ2
Performance District
WI-02
Senators
Tammy Baldwin
Ron Johnson
Ron Johnson
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Eye Institute, National Institutes of Health, Health and Human Services (075-0887) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,429,513 | 100% |
Modified: 8/20/24